Clinical Trial of CD19 and CD22 CAR Sequential Therapy Versus Single CD19 CAR Bridging to HSCT for r/r B-ALL Patients

Clinical trial NCT06343090 · RECRUITING

Trial details

NCT number: NCT06343090
Sponsor: Beijing GoBroad Hospital
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

B-cell Acute Lymphoblastic Leukemia Acute Lymphoblastic Leukemia, in Relapse Refractory Acute Lymphoid Leukemia

Start date: 2024-04-12
Primary completion: 2042-12-01
Enrollment: 353

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.